High-Dose Quadrivalent Influenza Vaccine
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for High-Dose Quadrivalent Influenza Vaccine, covering 2018-02-09 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older [Phase 3]